Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$57.04
+0.5%
$58.63
$42.52
$62.89
$115.93B0.2610.19 million shs10.82 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$6.37
-3.7%
$5.73
$4.40
$9.77
$1.19B2.085.63 million shs4.38 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$393.65
-1.4%
$316.82
$234.60
$404.15
$357.67B0.648.53 million shs9.66 million shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.49%+1.68%-1.51%-5.94%+29.46%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-3.49%-12.18%+14.79%+36.73%-13.05%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-1.30%+3.73%+25.30%+34.20%+27.66%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$57.04
+0.5%
$58.63
$42.52
$62.89
$115.93B0.2610.19 million shs10.82 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$6.37
-3.7%
$5.73
$4.40
$9.77
$1.19B2.085.63 million shs4.38 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$393.65
-1.4%
$316.82
$234.60
$404.15
$357.67B0.648.53 million shs9.66 million shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.49%+1.68%-1.51%-5.94%+29.46%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-3.49%-12.18%+14.79%+36.73%-13.05%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-1.30%+3.73%+25.30%+34.20%+27.66%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.37
Hold$61.317.49% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.22
Hold$7.5318.32% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.72
Moderate Buy$378.88-3.75% Downside

Current Analyst Ratings Breakdown

Latest TDOC, BMY, and UNH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
UpgradeSell (D+)Hold (C-)
5/5/2026
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Boost Price TargetNeutral$6.00 ➝ $7.00
5/1/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Reiterated RatingNeutral
4/28/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOverweight$389.00 ➝ $420.00
4/27/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
UpgradeHoldBuy
4/23/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetHold$311.00 ➝ $337.00
4/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOverweight$375.00 ➝ $395.00
4/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOutperform$345.00 ➝ $400.00
4/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOutperform$361.00 ➝ $400.00
4/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOverweight$370.00 ➝ $397.00
4/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOutperform$385.00 ➝ $405.00
(Data available from 5/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.48B2.40$8.17 per share6.98$9.84 per share5.80
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.53B0.45$1.73 per share3.67$7.40 per share0.86
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$449.71B0.79$20.97 per share18.77$114.40 per share3.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$7.05B$3.5616.029.400.1615.01%64.87%13.16%7/30/2026 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$200.32M-$0.97N/AN/AN/A-6.81%-11.45%-5.54%7/29/2026 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$12.06B$13.2429.7319.141.722.68%14.65%4.77%8/4/2026 (Estimated)

Latest TDOC, BMY, and UNH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.42$1.58+$0.16$1.31$10.93 billion$11.49 billion
4/29/2026Q1 2026
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.3454-$0.36-$0.0147-$0.36$611.04 million$613.85 million
4/21/2026Q1 2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.76$7.23+$0.47$6.90$109.84 billion$111.65 billion
2/25/2026Q4 2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.19-$0.14+$0.05-$0.14$635.33 million$642.27 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.524.42%+1.61%70.79%17 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.842.25%+12.57%66.77%15 Years

Latest TDOC, BMY, and UNH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/2/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.634.23%4/2/20264/2/20265/1/2026
2/24/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.213.1%3/9/20263/9/20263/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.10
1.42
1.28
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.75
2.80
2.72
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.80
0.80

Institutional Ownership

CompanyInstitutional Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.05%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.70%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
32,5002.04 billion2.04 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600180.51 million179.25 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
390,000908.14 million905.60 millionOptionable

Recent News About These Companies

Promising Healthcare Stocks To Follow Now - May 14th
Promising Healthcare Stocks To Research - May 13th
Medical Stocks To Keep An Eye On - May 13th
UnitedHealth: TrumpRx Is A Nothingburger
Dow Closes Above 50,000 for First Time in Months
Forget UnitedHealth: Two Stocks To Buy Now
UnitedHealth: Beaten Down, Not Broken

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$57.04 +0.27 (+0.47%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$56.76 -0.27 (-0.48%)
As of 05/15/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$6.36 -0.25 (-3.71%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$6.36 -0.01 (-0.09%)
As of 05/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$393.65 -5.44 (-1.36%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$375.64 -18.01 (-4.57%)
As of 05/15/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.